06/09/2026
We use leukocyte-poor for intraarticular, leukocyte-rich for tib fib joint, ACL, and meniscus.
The composition of PRP changes based on what tissue we're treating. Leukocyte-poor for the joint space, leukocyte-rich for ligaments, tendons, and meniscus tears. We're not using a one-size-fits-all approach—we're customizing the biological profile based on current research and what each specific tissue needs to regenerate.
This is why asking "Does PRP work?" is the wrong question. The right question is: what type of PRP, at what concentration, placed where, and for what condition?
What questions do you have about different PRP formulations? Let's break it down below.